Dow Jones

38 711,29

0,00%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Priveterra Acquisition Corporation II (PMGM)
Priveterra Acquisition Corporation II (PMGM) Actualités

PMGM

Priveterra Acquisition C... (PMGM)

Priveterra Acquisition Corporation II

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:PMGM

Date	Heure	Source	Titre	Symbole	Société
03/05/2024	23h30	Business Wire	Priveterra Acquisition Corp. II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K	NASDAQ:PMGM	Priveterra Acquisition Corporation II
21/07/2023	22h27	Business Wire	Priveterra Acquisition Corp. Announces Completion of Business Combination with AEON Biopharma, Inc.	NASDAQ:PMGM	Priveterra Acquisition Corporation II
17/07/2023	23h02	Business Wire	Priveterra Acquisition Corp. Announces Authorization to List on NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.	NASDAQ:PMGM	Priveterra Acquisition Corporation II
12/07/2023	00h40	Business Wire	Priveterra Acquisition Corp. Announces Intention to Transfer to NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.	NASDAQ:PMGM	Priveterra Acquisition Corporation II
30/06/2023	14h28	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
30/06/2023	14h27	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
30/06/2023	12h06	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
12/06/2023	22h43	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
17/05/2023	22h06	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
15/05/2023	12h38	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
12/05/2023	23h01	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (definitive) (defm14a)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
12/05/2023	22h34	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
09/05/2023	20h08	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
10/04/2023	22h58	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
31/03/2023	23h34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
31/03/2023	23h07	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
10/03/2023	22h34	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
22/12/2022	12h03	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
13/12/2022	12h02	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
28/03/2022	22h17	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
03/03/2022	14h19	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
03/03/2022	14h15	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	NASDAQ:PMGM	Priveterra Acquisition Corporation II
11/08/2021	02h05	GlobeNewswire Inc.	RxSight Announces Appointments to its Board of Directors	NASDAQ:PMGM	Priveterra Acquisition Corporation II
17/05/2021	22h07	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:PMGM	Priveterra Acquisition Corporation II